Hawryluk P. Kent
President & CEO at MBX
- Sold, on record
- $18k
- Dollars the filings state
- Form 4 sales
- 1
- Latest May 6, 2026
- Form 144 notices
- 3
- Proposed sales
- Quarters with a sale
- 1 of the last 8
- 1 day with a sale in that time
- Companies
- 1
- Filed as an executive or holder
Companies
- MBXMBX Biosciences, Inc.President & CEO
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- Aug 17, 2026Notice
Filed a notice to sell 3,745 shares
$256k3,745 shares
- Aug 4, 2026Notice
Filed a notice to sell 936 shares
$62k936 shares
- May 6, 2026No plan
Sold 0.1% of their holdings
$18k607 shares at $29.54
- May 6, 2026Notice
Filed a notice to sell 607 shares
$18k607 shares
4 of 4
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | May 8, 2026 | MBX | President & CEO | Sold | 607 | $29.54 | $18k | 727,667 | SEC |
| Mar 13, 2026 | Mar 16, 2026 | MBX | President & CEO | Bought | 18,500 | $28.41 | $526k | 486,777 | SEC |
| Feb 26, 2026 | Feb 27, 2026 | MBX | President & CEO | Exercised or settledStock option (right to buy) | 28,768 | 91,668 | SEC | ||
| Feb 26, 2026 | Feb 27, 2026 | MBX | President & CEO | Exercised options | 28,768 | $16.00 | $460k | 728,274 | SEC |
| Feb 2, 2026 | Feb 3, 2026 | MBX | President & CEO | AwardedStock option (right to buy) | 164,500 | 164,500 | SEC | ||
| Feb 2, 2026 | Feb 3, 2026 | MBX | President & CEO | Awarded | 35,250 | 699,506 | SEC | ||
| Oct 24, 2025 | Oct 28, 2025 | MBX | President & CEO | Exercised or settledStock option (right to buy) | 182,859 | 129,708 | SEC | ||
| Oct 24, 2025 | Oct 28, 2025 | MBX | President & CEO | Exercised options | 182,859 | $3.25 | $594k | 664,256 | SEC |
| Oct 20, 2025 | Oct 21, 2025 | MBX | President & CEO | Bought | 20,000 | $13.64 | $273k | 468,277 | SEC |
| Feb 4, 2025 | Feb 5, 2025 | MBX | President & CEO | Bought | 50,000 | $10.69 | $535k | 448,277 | SEC |
| Feb 3, 2025 | Feb 5, 2025 | MBX | President & CEO | AwardedStock Option (Right to Buy) | 243,000 | 243,000 | SEC | ||
| Sep 16, 2024 | Sep 17, 2024 | MBX | President & CEO | ConvertedSeries A Convertible Preferred Stock | 4.8M | 0 | SEC | ||
| Sep 16, 2024 | Sep 17, 2024 | MBX | President & CEO | Converted | 399,760 | 398,277 | SEC | ||
| Sep 12, 2024 | Sep 13, 2024 | MBX | President & CEO | AwardedStock Option (Right to Buy) | 120,436 | 120,436 | SEC | ||
| Jan 29, 2018 | Jan 30, 2018 | MTVA | Director | AwardedStock Option (right to buy) | 10,800 | 10,800 | SEC | ||
| Mar 10, 2017 | Mar 14, 2017 | MTVA | Director | BoughtWarrant to Purchase Common Stock | 18,750 | $9.47 | $178k | 18,750 | SEC |
| Mar 10, 2017 | Mar 14, 2017 | MTVA | Director | Bought | 25,000 | $9.47 | $237k | 81,889 | SEC |
| Aug 10, 2016 | Aug 12, 2016 | MTVA | Director | Bought | 25,000 | $10.00 | $250k | 56,889 | SEC |
| Aug 10, 2016 | Aug 12, 2016 | MTVA | Director | Other | 816 | $6.71 | $5k | 8,273 | SEC |
| Aug 10, 2016 | Aug 12, 2016 | MTVA | Director | ConvertedSeries A Convertible Preferred Stock | 7,457 | 0 | SEC | ||
| Aug 10, 2016 | Aug 12, 2016 | MTVA | Director | Converted | 31,073 | $5.10 | $158k | 31,889 | SEC |
| Aug 4, 2016 | Aug 8, 2016 | MTVA | Director | AwardedStock Option (right to buy) | 60,000 | 60,000 | SEC |
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 17, 2026 | MBX | President & CEO | Form 144 notice | 3,745 | $256k | Notice | SEC | |
| Aug 4, 2026 | Aug 4, 2026 | MBX | President & CEO | Form 144 notice | 936 | $62k | Notice | SEC | |
| May 6, 2026 | May 8, 2026 | MBX | President & CEO | Form 4 sale | 607 | $18k | 0.1% | No plan | SEC |
| May 6, 2026 | May 6, 2026 | MBX | President & CEO | Form 144 notice | 607 | $18k | Notice | SEC |